GSTM1 and laryngotracheoesophageal cleft: Li et al. [18] only examined seven studies (809 LC cases and 935 controls) and their meta-analysis indicated that the combined effects of GSTM1 present/null and CYP1A1 MspI polymorphisms were significantly associated with an increased LC risk.